{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:13:50Z","timestamp":1790140430105,"version":"4.0.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,1,2]],"date-time":"2017-01-02T00:00:00Z","timestamp":1483315200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s10147-016-1075-9","type":"journal-article","created":{"date-parts":[[2017,1,2]],"date-time":"2017-01-02T02:52:40Z","timestamp":1483325560000},"page":"548-553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Skeletal-related events and prognosis in urothelial cancer patients with bone metastasis"],"prefix":"10.1007","volume":"22","author":[{"given":"Yusuke","family":"Tsuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4041-7241","authenticated-orcid":false,"given":"Tohru","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Shinoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kanatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taketo","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Kume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Homma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakae","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,2]]},"reference":[{"key":"1075_CR1","unstructured":"Ferlay J, Soerjomataram I, Ervik M et al (2013) GLOBOCAN 2012 v1.0. Cancer incidence and mortality worldwide. IARC CancerBase No. 11. http:\/\/globocan.iarc.fr . Accessed April 2016"},{"key":"1075_CR2","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1200\/JCO.2000.18.17.3068","volume":"18","author":"H Maase von der","year":"2000","unstructured":"von der Maase H, Hansen SW, Roberts JT et al (2000) Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 18:3068\u20133077","journal-title":"J Clin Oncol"},{"key":"1075_CR3","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.juro.2012.10.065","volume":"189","author":"T Nakagawa","year":"2013","unstructured":"Nakagawa T, Hara T, Kawahara T et al (2013) Prognostic risk stratification of patients with urothelial carcinoma of the bladder with recurrence after radical cystectomy. J Urol 189:1275\u20131281","journal-title":"J Urol"},{"key":"1075_CR4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-5347(01)66562-5","volume":"155","author":"L Sengel\u00f8v","year":"1996","unstructured":"Sengel\u00f8v L, Kamby C, von der Maase H (1996) Pattern of metastases in relation to characteristics of primary tumor and treatment in patients with disseminated urothelial carcinoma. J Urol 155:111\u2013114","journal-title":"J Urol"},{"key":"1075_CR5","doi-asserted-by":"crossref","first-page":"E148","DOI":"10.5489\/cuaj.787","volume":"8","author":"M Bianchi","year":"2014","unstructured":"Bianchi M, Roghmann F, Becker A et al (2014) Age-stratified distribution of metastatic sites in bladder cancer: a population-based analysis. Can Urol Assoc J 8:E148\u2013E158","journal-title":"Can Urol Assoc J"},{"key":"1075_CR6","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1158\/1078-0432.CCR-06-0931","volume":"12","author":"RE Coleman","year":"2006","unstructured":"Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12:6243\u20136249","journal-title":"Clin Cancer Res"},{"key":"1075_CR7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2214\/AJR.10.5036","volume":"196","author":"AB Shinagare","year":"2011","unstructured":"Shinagare AB, Ramaiya NH, Jagannathan JP et al (2011) Metastatic pattern of bladder\u00a0cancer: correlation with the characteristics of the primary tumor. AJR Am J Roentgenol 196:117\u2013122","journal-title":"AJR Am J Roentgenol"},{"key":"1075_CR8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/RCT.0b013e31820d7a37","volume":"35","author":"AB Shinagare","year":"2011","unstructured":"Shinagare AB, Fennessy FM, Ramaiya NH et al (2011) Urothelial cancers of the upper urinary tract: metastatic pattern and its correlation with tumor histopathology and location. J Comput Assist Tomogr 35:217\u2013222","journal-title":"J Comput Assist Tomogr"},{"key":"1075_CR9","first-page":"201","volume":"218","author":"S David","year":"1987","unstructured":"David S, Grady M (1987) Surgical management of thoracolumbar spine fractures with incomplete neurologic deficits. Clin Orthop Relat Res 218:201\u2013206","journal-title":"Clin Orthop Relat Res"},{"key":"1075_CR10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2214\/ajr.129.1.61","volume":"129","author":"GS Forbes","year":"1977","unstructured":"Forbes GS, McLeod RA, Hattery RR (1977) Radiographic manifestations of bone metastases from renal carcinoma. AJR Am J Roentgenol 129:61\u201366","journal-title":"AJR Am J Roentgenol"},{"key":"1075_CR11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrclinonc.2011.67","volume":"8","author":"J Sturge","year":"2011","unstructured":"Sturge J, Caley MP, Waxman J (2011) Bone metastasis in prostate cancer: emerging therapeutic strategies. Nat Rev Clin Oncol 8:357\u2013368","journal-title":"Nat Rev Clin Oncol"},{"key":"1075_CR12","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1442-2042.2010.02468.x","volume":"17","author":"A Yokomizo","year":"2010","unstructured":"Yokomizo A, Koga H, Shinohara N et al (2010) Skeletal-related events in urological cancer patients with bone metastasis: a multicenter study in Japan. Int J Urol 17:332\u2013336","journal-title":"Int J Urol"},{"key":"1075_CR13","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.juro.2010.12.037","volume":"185","author":"H Kume","year":"2011","unstructured":"Kume H, Kakutani S, Yamada Y et al (2011) Prognostic factors for renal cell carcinoma with bone metastasis: who are the long-term survivors? J Urol 185:1611\u20131614","journal-title":"J Urol"},{"key":"1075_CR14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3171\/2010.6.SPINE10167","volume":"13","author":"DM Drzymalski","year":"2010","unstructured":"Drzymalski DM, Oh WK, Werner L et al (2010) Predictors of survival in patients with prostate cancer and spinal metastasis. J Neurosurg Spine 13:789\u2013794","journal-title":"J Neurosurg Spine"},{"key":"1075_CR15","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/jjco\/hyt096","volume":"43","author":"S Taguchi","year":"2013","unstructured":"Taguchi S, Nakagawa T, Hattori M et al (2013) Prognostic factors for metastatic urothelial carcinoma undergoing cisplatin-based salvage chemotherapy. Jpn J Clin Oncol 43:923\u2013928","journal-title":"Jpn J Clin Oncol"},{"key":"1075_CR16","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s10147-010-0074-5","volume":"15","author":"MS Zaghloul","year":"2010","unstructured":"Zaghloul MS, Boutrus R, El-Hossieny H et al (2010) A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer. Int J Clin Oncol 15:382\u2013389","journal-title":"Int J Clin Oncol"},{"key":"1075_CR17","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0140-6736(10)62051-X","volume":"376","author":"GJ Morgan","year":"2010","unstructured":"Morgan GJ, Davies FE, Gregory WM et al (2010) First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial. Lancet 376:1989\u20131999","journal-title":"Lancet"},{"key":"1075_CR18","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/JTO.0b013e31826aec2b","volume":"7","author":"GV Scagliotti","year":"2012","unstructured":"Scagliotti GV, Hirsh V, Siena S et al (2012) Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study. J Thorac Oncol 7:1823\u20131829","journal-title":"J Thorac Oncol"},{"key":"1075_CR19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/00365590802475904","volume":"43","author":"A Ullen","year":"2009","unstructured":"Ullen A, Schwarz S, Lennartsson L et al (2009) Zoledronic acid induces caspase-dependent apoptosis in renal cancer cell lines. Scand J Urol Nephrol 43:98\u2013103","journal-title":"Scand J Urol Nephrol"},{"key":"1075_CR20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00262-008-0571-9","volume":"58","author":"T Yuasa","year":"2009","unstructured":"Yuasa T, Sato K, Ashihara E et al (2009) Intravesical administration of gamma-delta T cells successfully prevents the growth of bladder cancer in the murine model. Cancer Immunol Immunother 58:493\u2013502","journal-title":"Cancer Immunol Immunother"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-016-1075-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-016-1075-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-016-1075-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T23:14:51Z","timestamp":1568675691000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-016-1075-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,2]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["1075"],"URL":"https:\/\/doi.org\/10.1007\/s10147-016-1075-9","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,2]]}}}